Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absent, ATM, avenue, backed, Bill, CAGR, Center, CEO, COO, Council, counterfeit, CR, cybersecurity, debated, dossier, draft, easily, founder, granularity, grew, HIV, Hodgkin, intentionally, irrespective, landscape, MAA, MD, onboarding, overarching, pace, PET, PhD, Portal, predecessor, Qualitative, Quantitative, randomly, Rescue, revert, RTOR, somatic, stolen, streamline, subgroup, Taiwan, threat, top, Traditionally, triple, unfit, unified, VP
Removed:
adjudicating, adjust, BBA, Bipartisan, campaign, capita, clean, consideration, CTA, emergency, executed, Favored, FcgRI, FcgRIIb, FcgRIIIa, forfeited, Forfeiture, fractional, harmonization, implanted, infused, inhaled, injected, instilled, instituted, interrupted, lender, lessee, loan, mediated, methodology, MFN, monthly, Nation, nurse, objective, overcome, Pacific, permission, prolonged, provisional, publicly, recapitalization, renewed, reorganization, repealed, retrospective, reversion, shell, shutdown, strain, surrendered, timeline, tribunal, unclear, wake, Western, Wuhan
Filing tables
Filing exhibits
Related press release
CMPX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-252103) and Form S-3 (File Nos. 333-257821 and 333-268652) of Compass Therapeutics, Inc. of our report dated March 21, 2024 on our audits of the consolidated financial statements of Compass Therapeutics, Inc. and subsidiaries as of December 31, 2023 and 2022 and for each of the two years in the period ended December 31, 2023, which is included in this Annual Report on Form 10-K of Compass Therapeutics, Inc. for the year ended December 31, 2023.
/s/ CohnReznick LLP
Melville, New York
March 21, 2024